Treatment of advanced mesothelioma with the recombinant adenovirus H5.010RSVTK: a phase 1 trial (BB-IND 6274)

Hum Gene Ther. 1996 Oct 20;7(16):2047-57. doi: 10.1089/hum.1996.7.16-2047.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I

MeSH terms

  • Adenoviruses, Human / genetics*
  • Antiviral Agents / pharmacology*
  • Clinical Protocols
  • Ganciclovir / pharmacology*
  • Genetic Vectors*
  • Herpesvirus 1, Human / enzymology*
  • Humans
  • Mesothelioma / therapy*
  • Recombination, Genetic
  • Thymidine Kinase / genetics
  • Thymidine Kinase / therapeutic use*

Substances

  • Antiviral Agents
  • Thymidine Kinase
  • Ganciclovir